clinical trial · NCT05505643
Cryoablation vs Lumpectomy in T1 Breast Cancers
Breast CancerBreast NeoplasmEndocare SlimLine CryoprobeLumpectomy
brief summary
This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a method of killing a tumor by freezing it. The standard approach for patients with this kind of cancer is a lumpectomy. This study will review the safety of the cryoablation procedure initially, followed by comparing cryoablation to lumpectomy in order to see if the cryoablation results in better disease control, complication rates, and quality of life.
started
Apr 3, 2024
primary completion
Apr 30, 2033
completion
Apr 30, 2033
last updated
Feb 27, 2026
official title
COOL-IT: Cryoablation vs Lumpectomy in T1 Breast Cancers: A Randomized Controlled Trial With Safety Lead-in
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol